Personal neoantigen vaccine prompts strong anti-tumor response in patients, study shows - Science Daily

Personal neoantigen vaccine prompts strong anti-tumor response in patients, study shows Science Daily A personal cancer treatment vaccine that targets distinctive "neoantigens" on tumor cells has been shown to stimulate a potent, safe, and highly specific immune anti-tumor response in melanoma patients, report scientists from Dana-Farber Cancer ... and more »

from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2sVX4rm
via IFTTT